Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry
1 other identifier
observational
11
1 country
1
Brief Summary
The purpose of this study is to conduct a SpO2 hypoxia evaluation of the Oxitone Medical Oxitone 1000 pulse oximeter. The Oxitone 1000 pulse oximeter will be evaluated during non-motion conditions over the range of 70-100% SpO2 in comparison to a Reference Pulse Oximeter. The study is observational in nature which quantifies device performance and accuracy in compassion to a Reference Pulse Oximeter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 10, 2016
CompletedFirst Posted
Study publicly available on registry
August 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedApril 20, 2017
April 1, 2017
1 month
August 10, 2016
April 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Collect SpO2 data for accuracy statistical analysis by 12 subjects
Data is collected in a digital form for 4-6 SpO2 stable plateaus in a specified range from 100% to 70%.
2 months
Accuracy data analysis
Bland-Altman graphical plots. An Accuracy Root Mean Square (ARMS) calculation is used as a means to define the SpO2 accuracy. Data analysis will follow ISO80601-2-61, Annex EE and the FDA Guidance Document for Pulse Oximeters (Martch 4, 2013).
2 months
Secondary Outcomes (1)
Error plots
2 months
Study Arms (1)
Healthy volunteer
Smoker or non-smoker
Interventions
Measurement of physiological parameters
Eligibility Criteria
Residents of the Denver metropolitan area
You may qualify if:
- Healthy individuals between the age of 18-50
You may not qualify if:
- Clotting disorders, diabetes, currently taking psychotropic medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oxitone Medical Ltd.lead
- Clinimark, LLCcollaborator
Study Sites (1)
Clinimark Laboratories
Louisville, Colorado, 80027, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leon Eisen, PhD
Oxitone Medical Ltd.
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Leon Eisen, CEO
Study Record Dates
First Submitted
August 10, 2016
First Posted
August 17, 2016
Study Start
August 1, 2016
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
April 20, 2017
Record last verified: 2017-04